Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Safety and Effectiveness in Moderate to Severe Plaque Psoriasis (Russia)
NCT01644396Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2012
- Primary completion
- Sep 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in plaque psoriasis, sponsored by AbbVie Inc.. Started May 2012; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01644396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01644396.